Higher expression of ISG20 was associated with suppressed adaptive immune responses, increased infiltration of monocyte-derived macrophages and neutrophils, higher tumor grade, and poorer clinical outcome in glioma [26]. The gene discussed is ISG20; the disease is central nervous system cancer.